PATENT CLAIM ANALYSIS

Application Number: 15745207
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-12
Patent Classification: ["435", "069700"]

Abstract:
Disclosed in the present invention is a long-acting recombinant human follicle-stimulating hormone-Fc fusion protein (referred to as hFSH-Fc for short) and a preparation method thereof, wherein the hFSH-Fc protein is a dimerized fusion protein and the amino acid sequence thereof successively comprises an hFSHβ subunit, CTP, an hFSHα subunit, a flexible peptide linker and human IgG2 Fc variant from N-terminal to C-terminal. Also disclosed in the present invention is the use of the recombinant hFSH-Fc fusion protein composition in preparing drugs in the animal breeding field.

Claim (Index 1):
A recombinant hFSH-Fc fusion protein, wherein the fusion protein is a dimerized fusion protein, and the amino acid sequence of the fusion protein sequentially comprises an hFSH\u03b2 subunit, CTP, an hFSH\u03b1 subunit, a peptide linker and human IgG2 Fc variant from N-terminal to C-terminal.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 86.0
- Lexical Diversity: 1.59322
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['11045022', '10112321', '10119427', '14898698', '11490825']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6293210587842898
- 35 USC 102 Novelty (BERT): 0.5190724089497206
- Combined Prediction Score: 0.6182961938008329
- Mean Citation Score: 329.981784
- Max Citation Score: 334.7434
- Similarity Product: 266.4583813754559

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test